Pathophysiology And Management of Cystic Fibrosis

Participants will gain an understanding of the fundamental pathophysiology of CF, particularly how genetic mutations affect multiple organ systems, leading to progressive complications. The session reviews current diagnostic methods and treatment options, highlighting advancements in CF care, including therapies targeting underlying genetic defects. The discussion also explores different mutation classes and the growing shift in CF management, demonstrating how personalized therapies offer new possibilities for improving patient outcomes.

Emerging therapeutic approaches, such as CFTR modulators, gene therapy, and mucus-clearing treatments, will be examined, emphasizing their role in modifying disease progression and improving lung function. The session will also address the importance of multidisciplinary care, including pulmonary therapies, nutritional support, and infection control strategies.

Additionally, participants will learn how evolving guidelines influence early diagnosis and proactive treatment plans, ensuring optimal management for diverse patient populations. By integrating these insights, pediatricians will be better prepared to recognize, diagnose, and manage CF effectively in clinical practice, leading to improved life expectancy and quality of care for individuals with the condition.